SCHEMBL4958839

SCHEMBL4958839

CCCCc1nc2ccccc2c(=O)n1-c1cc(C)c(N)cc1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2C9 P11712 2/20 0.59
CYP2C19 P33261 2/20 0.59
LMNA P02545 3/20 0.58
MAPK1 P28482 1/20 0.58
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
MAPT P10636 2/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
ATM Q13315 1/20 0.54
TSHR P16473 1/20 0.53
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52
PDE10A Q9Y233 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959071 0.85 ALDH1A1 (0.76) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4957379 0.84 ALDH1A1 (0.65) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4954037 0.82 ALDH1A1 (0.71) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4959292 0.81 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4960701 0.80 LMNA (0.61) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4960778 0.78 LMNA (0.62) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4958923 0.78 LMNA (0.80) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4959746 0.78 ALDH1A1 (0.71) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4960645 0.77 LMNA (0.67) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4955885 0.77 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed